HDAC6 is required for invadopodia activity and invasion by breast tumor cells

被引:77
|
作者
Rey, Mercedes [1 ,2 ]
Irondelle, Marie [1 ,2 ]
Waharte, Francois [1 ,3 ]
Lizarraga, Floria [1 ,2 ]
Chavrier, Philippe [1 ,2 ]
机构
[1] Inst Curie, Res Ctr, F-75248 Paris 05, France
[2] CNRS, UMR144, F-75248 Paris 05, France
[3] Inst Curie, CNRS, Cell & Tissue Imaging Facil, PICT IBiSA,UMR 144, F-75248 Paris 05, France
关键词
Invadopodia; Acetylation; Histone deacetylase; HDAC6; Tumor cell invasion; EXTRACELLULAR-MATRIX DEGRADATION; IN-VIVO; BASEMENT-MEMBRANE; CONTACT SITES; CANCER; ACETYLATION; CORTACTIN; METALLOPROTEINASE; MICROTUBULES; DEACETYLASE;
D O I
10.1016/j.ejcb.2010.09.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Invasion across tissue boundaries by metastatic tumor cells depends on the proteolytic degradation of the extracellular matrix, initiated by the formation of invadopodia, actin-driven membrane protrusions with matrix-degradative activity. Yet, mechanisms underlying invadopodia formation remain largely unknown. In this report, we examined the role of the histone deacetylase HDAC6 in invadopodia formation and invasion by breast cancer cells. Using small interfering RNA silencing of protein expression in highly invasive MDA-MB-231 breast adenocarcinoma cells, we show that HDAC6 is required for two-dimensional matrix proteolysis. In addition, we demonstrate that HDAC6 acts as a tubulin and cortactin deacetylase. We also report that the inhibition of HDAC6 by siRNA or treatment with HDAC inhibitor TSA results in a decreased invasion capacity of a three-dimensional type I collagen matrix by MDA-MB-231 cells. These data identify HDAC6 as a critical component of the invasive apparatus of tumor cells, in both two- and three-dimensional matrices. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [1] HDAC6 Deacetylase Activity Is Required for Hypoxia-Induced Invadopodia Formation and Cell Invasion
    Arsenault, Dominique
    Brochu-Gaudreau, Karine
    Charbonneau, Martine
    Dubois, Claire M.
    PLOS ONE, 2013, 8 (02):
  • [2] Diaphanous-Related Formins Are Required for Invadopodia Formation and Invasion of Breast Tumor Cells
    Lizarraga, Floria
    Poincloux, Renaud
    Romao, Maryse
    Montagnac, Guillaume
    Le Dez, Gaelle
    Bonne, Isabelle
    Rigaill, Guillem
    Raposo, Graca
    Chavrier, Philippe
    CANCER RESEARCH, 2009, 69 (07) : 2792 - 2800
  • [3] HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells
    Watson, Gregory W.
    Wickramasekara, Samanthi
    Fang, Yufeng
    Maier, Claudia S.
    Williams, David E.
    Dashwood, Roderick H.
    Perez, Viviana I.
    Ho, Emily
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (11) : 1177 - 1185
  • [4] Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
    Jiaqi Liu
    Jianying Gu
    Zihao Feng
    Yanhong Yang
    Ningwen Zhu
    Weiyue Lu
    Fazhi Qi
    Journal of Translational Medicine, 14
  • [5] Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
    Liu, Jiaqi
    Gu, Jianying
    Feng, Zihao
    Yang, Yanhong
    Zhu, Ningwen
    Lu, Weiyue
    Qi, Fazhi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [6] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Zeleke, Tizita Z.
    Pan, Qingfei
    Chiuzan, Codruta
    Onishi, Maika
    Li, Yuxin
    Tan, Haiyan
    Alvarez, Mariano J.
    Honan, Erin
    Yang, Min
    Chia, Pei Ling
    Mukhopadhyay, Partha
    Kelly, Sean
    Wu, Ruby
    Fenn, Kathleen
    Trivedi, Meghna S.
    Accordino, Melissa
    Crew, Katherine D.
    Hershman, Dawn L.
    Maurer, Matthew
    Jones, Simon
    High, Anthony
    Peng, Junmin
    Califano, Andrea
    Kalinsky, Kevin
    Yu, Jiyang
    Silva, Jose
    NATURE CANCER, 2023, 4 (02) : 257 - +
  • [7] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Tizita Z. Zeleke
    Qingfei Pan
    Codruta Chiuzan
    Maika Onishi
    Yuxin Li
    Haiyan Tan
    Mariano J. Alvarez
    Erin Honan
    Min Yang
    Pei Ling Chia
    Partha Mukhopadhyay
    Sean Kelly
    Ruby Wu
    Kathleen Fenn
    Meghna S. Trivedi
    Melissa Accordino
    Katherine D. Crew
    Dawn L. Hershman
    Matthew Maurer
    Simon Jones
    Anthony High
    Junmin Peng
    Andrea Califano
    Kevin Kalinsky
    Jiyang Yu
    Jose Silva
    Nature Cancer, 2023, 4 : 257 - 275
  • [8] HDAC6 IS A NOVEL REGULATOR OF MTOR ACTIVITY IN COLORECTAL CANCER CELLS
    Zhou, Yuning
    Wang, Qingding
    Weiss, Heidi L.
    Evers, B. Mark
    GASTROENTEROLOGY, 2018, 154 (06) : S874 - S874
  • [9] HDAC6 modulates colon cancer cell migration and invasion
    Li, Hui
    CANCER RESEARCH, 2020, 80 (16)
  • [10] HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin
    Iwata, A
    Riley, BE
    Johnston, JA
    Kopito, RR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) : 40282 - 40292